Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Bioequivalence of SPIL's Estradiol Vaginal Tablet in Vulvar and Vaginal Atrophy
NCT01753102Phase 3Terminated
- Sponsor
- Sun Pharma
- Start
- Nov 2012
- Primary completion
- Apr 2013
- Modality
- Hormone, Biologic
- Countries
- 1
01
Overview
A Phase 3 trial of estradiol in vulvar atrophy, vaginal atrophy, sponsored by Sun Pharma. Started Nov 2012; status: terminated.
02
Drugs
estradiol
03
Conditions
vulvar atrophyvaginal atrophy
Beyond the preview
Go deeper on NCT01753102.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01753102.